Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

6.13
-0.2100-3.31%
Post-market: 6.230.1000+1.63%19:30 EDT
Volume:835.40K
Turnover:5.21M
Market Cap:118.56M
PE:-1.01
High:6.68
Open:6.59
Low:6.06
Close:6.34
52wk High:20.56
52wk Low:6.06
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.12
T/O Rate:4.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.16
PE(LYR):-1.04

Loading ...

Wedbush Remains a Buy on Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 13

Corbus Pharma CEO presents at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 13

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13

Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies

TIPRANKS
·
May 13

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 13

Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)

TIPRANKS
·
May 13

Corbus Pharmaceuticals Q1 EPS $(1.23) Misses $(1.22) Estimate

Benzinga Earnings
·
May 12

Corbus Q1 FY26 net loss widens to $23 million; operating expenses rise to $24.3 million

Reuters
·
May 12

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

THOMSON REUTERS
·
May 12

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

Corbus hosts ASCO KOL event on updated CRB-701 HNSCC Phase 1/2 data

Reuters
·
May 05

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
May 05

MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts

TIPRANKS
·
May 02

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 4.3%, Outperforms Peers

Dow Jones
·
May 02

Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.22 a share - Earnings Preview

Reuters
·
May 01

Corbus Pharmaceuticals Initiated at Buy by Guggenheim

Dow Jones
·
Apr 30

U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings

Reuters
·
Apr 29

Corbus Pharmaceuticals Holdings Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $45

THOMSON REUTERS
·
Apr 29

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Corbus Pharmaceuticals initiated with a Buy at Guggenheim

TIPRANKS
·
Apr 29